Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$327M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$271M |
| 3 |
Chevron
CVX
|
+$264M |
| 4 |
JPMorgan Chase
JPM
|
+$233M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Johnson & Johnson
JNJ
|
+$396M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
Walmart Inc
WMT
|
+$285M |
| 5 |
Intuitive Surgical
ISRG
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.72% |
| 2 | Technology | 15.53% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Real Estate | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAG
2676
DELISTED
MAG Silver
MAG
| $832K | ﹤0.01% |
+102,600
| New | +$891K |
|
2677
Tiptree Inc
TIPT
$668M
| $827K | ﹤0.01% |
126,303
+75,903
| +151% | +$506K |
|
2678
UNIFI
UFI
$127M
| $827K | ﹤0.01% |
29,200
-54,300
| -65% | -$1.7M |
|
|
AKAO
2679
DELISTED
Achaogen Inc
AKAO
| $824K | ﹤0.01% |
+206,500
| New | +$1.25M |
|
|
VLRS
2680
Controladora Vuela Compania de Aviacion
VLRS
$922M
| $823K | ﹤0.01% |
110,300
+91,100
| +474% | +$651K |
|
|
INWK
2681
DELISTED
InnerWorkings, Inc.
INWK
| $819K | ﹤0.01% |
103,400
-431,900
| -81% | -$3.39M |
|
|
BSJI
2682
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
| $819K | ﹤0.01% |
32,600
-31,000
| -49% | -$778K |
|
2683
iShares MSCI Australia ETF
EWA
$1.45B
| $818K | ﹤0.01% |
+37,000
| New | +$833K |
|
2684
SB Financial Group
SBFG
$171M
| $814K | ﹤0.01% |
42,000
-7,875
| -16% | -$151K |
|
|
AIMT
2685
DELISTED
Aimmune Therapeutics
AIMT
| $813K | ﹤0.01% |
29,800
-28,500
| -49% | -$806K |
|
2686
AMREP Corp
AXR
$118M
| $812K | ﹤0.01% |
111,080
+1,000
| +0.9% | +$7.72K |
|
2687
Alamo Group
ALG
$2.01B
| $809K | ﹤0.01% |
8,834
-36,466
| -80% | -$3.43M |
|
|
CCM
2688
Concord Medical Services
CCM
$20.8M
| $809K | ﹤0.01% |
22,780
+40
| +0.2% | +$1.41K |
|
|
PLYA
2689
DELISTED
Playa Hotels & Resorts
PLYA
| $804K | ﹤0.01% |
83,500
-240,700
| -74% | -$2.47M |
|
2690
StoneX
SNEX
$8.05B
| $804K | ﹤0.01% |
+84,286
| New | +$898K |
|
2691
ProShares Ultra S&P500
SSO
$8.51B
| $803K | ﹤0.01% |
50,400
-25,600
| -34% | -$391K |
|
|
SIFY
2692
Sify Technologies
SIFY
$1.14B
| $802K | ﹤0.01% |
88,417
+1,067
| +1% | +$11.4K |
|
2693
ImmuCell
ICCC
$99.3M
| $801K | ﹤0.01% |
96,100
+2,500
| +3% | +$18K |
|
|
SMIT
2694
DELISTED
Schmitt Industries Inc
SMIT
| $799K | ﹤0.01% |
284,410
+1,310
| +0.5% | +$3.49K |
|
2695
AMERISAFE
AMSF
$504M
| $793K | ﹤0.01% |
12,800
-21,500
| -63% | -$1.34M |
|
2696
First Trust North American Energy Infrastructure Fund
EMLP
$4.16B
| $793K | ﹤0.01% |
+33,800
| New | +$807K |
|
2697
UroGen Pharma
URGN
$2.34B
| $793K | ﹤0.01% |
16,800
-98,651
| -85% | -$4.58M |
|
|
MORL
2698
DELISTED
ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN
MORL
| $793K | ﹤0.01% |
+50,591
| New | +$815K |
|
2699
FreightCar America
RAIL
$243M
| $791K | ﹤0.01% |
49,200
-17,300
| -26% | -$298K |
|
2700
Sibanye-Stillwater
SBSW
$7.42B
| $789K | ﹤0.01% |
+316,830
| New | +$761K |
|
Similar funds
Jim Simons's Q3 2018 Portfolio in Review
As of Q3 2018, Jim Simons held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Jim Simons's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
- Jim Simons added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
- Jim Simons's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
- Jim Simons fully exited Apple in Q3 2018, selling an estimated $707M.
- Jim Simons's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
- Jim Simons opened 508 new positions and closed 410 in Q3 2018.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $97.3B.
Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.